Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Pharmacists play a crucial role in safe medication use and interdisciplinary collaboration is key to reducing antimicrobial resistance.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

A man developed skin issues from cancer medication, which improved with specific treatments.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Upadacitinib effectively treated alopecia areata when other treatments failed.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib helped a woman regrow hair with no major side effects.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.